Turnstone Biologics
Driving innate and adaptive tumor immunity to provide benefit to cancer patients underserved by current treatments.
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
* | N/A | Acquisition | |
| Total Funding | 000k | ||
F-Prime(exited)
Versant Ventures(exited)
OrbiMed(exited)
FACIT.com(exited)
Eight Roads Ventures(exited)
PFM Health Sciences(exited)
Point72 Ventures(exited)
Eventide Asset Management(exited)
Surveyor Capital(exited)
Ridgeback Capital(exited)
Takeda Ventures(exited)
CaaS Capital Management(exited)
JM Family Enterprises(exited)
Northleaf(exited)
404 Bio(exited)
Teralys Capital(exited)
Brace Pharma(exited)
Point72(exited)
| USD | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | (28 %) | (74 %) | - | - | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % EBITDA margin | 34 % | (38 %) | (291 %) | - | - | - | - |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | 33 % | (42 %) | (286 %) | - | - | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| R&D % of revenue | 54 % | 118 % | 313 % | - | - | - | - |
Source: Company filings or news article, Equity research estimates
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by Turnstone Biologics
Edit
ACQUISITION by Turnstone Biologics Jan 2021